Keezac Pharmacy Long Term Care Pharmacy Location: 111 Bedford Avenue, Bellmore, New York 11710 Phone: (516) 221-4022 |
Dr. Christopher R. Scheno, Od, Pllc Medicare Supplier Location: 2848 Bellmore Ave, Bellmore, New York 11710 Phone: (516) 409-2020 |
Cvs Pharmacy 2154 Durable Medical Equipment & Medical Supplies Location: 2145 Bellmore Ave, Bellmore, New York 11710 Phone: (516) 221-7694 |
Rite Aid Pharmacy #10628 Durable Medical Equipment & Medical Supplies Location: 2784 Sunrise Hwy, Bellmore, New York 11710 Phone: (516) 826-3100 |
News Archive
As a wide variety of nanoparticles continue to demonstrate their ability to improve the delivery of imaging agents and drugs to tumors, nanoparticle researchers have turned their attention to the challenge of systematically determining how a given nanoparticle's physical and chemical characteristics affect its ability to target tumors. Such data could provide drug developers with guidelines to help them select the most effective type of nanoparticle for a given therapeutic or imaging application.
Scientists searching for new drugs to fight malaria have identified a number of compounds - some of which are currently in clinical trials to treat cancer - that could add to the anti-malarial arsenal.
GlobalNet Services, Inc., a premier information technology provider for businesses and the Federal government, today announced that it was awarded a $6.2 million contract to support the U.S. Food and Drug Administration's (FDA) Agency Wide Business Objects Support (AWBOS). Under this five-year contract, which includes one base year and four option years, GlobalNet Services will support an Agency-wide SAP Business Objects implementation to report, manage and maintain public health information.
To test the severity of a viral infection, clinicians try to gauge how many viruses are packed into a certain volume of blood or other bodily fluid. This measurement, called viral load, helps doctors diagnose or monitor chronic viral diseases such as HIV/AIDS and hepatitis.
Cameron Health, Inc., developer of the world's only completely subcutaneous implantable defibrillator, announced today that it has completed a $107 million equity financing round led by Alloy Ventures and Delphi Ventures.
› Verified 5 days ago